This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Genfar S.A.
Genfar S.A., a prominent player in the pharmaceutical industry, is headquartered in Colombia (CO) and has established a significant presence across Latin America. Founded in 1980, the company has consistently focused on the development, manufacturing, and distribution of high-quality generic medicines, catering to a diverse range of therapeutic areas. With a commitment to innovation, Genfar S.A. offers a unique portfolio of products that includes injectables, oral medications, and specialised formulations. The company is recognised for its rigorous quality standards and adherence to international regulations, positioning it as a trusted provider in the healthcare sector. Over the years, Genfar has achieved notable milestones, solidifying its reputation as a leader in the pharmaceutical market, dedicated to improving patient outcomes through accessible healthcare solutions.
DitchCarbon Score
How does Genfar S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genfar S.A.'s score of 52 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genfar S.A., headquartered in Colombia, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Eurofarma Laboratórios S.A., which may influence its climate commitments and emissions reporting. As of now, Genfar S.A. has not established any documented reduction targets or climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy. Given its relationship with Eurofarma Laboratórios S.A., any potential emissions data or climate commitments may be inherited from this parent company. However, no specific figures or targets have been provided in the available information. In summary, while Genfar S.A. is part of a larger corporate family that may have climate initiatives, it currently lacks detailed emissions data and defined reduction targets.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 12,594,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 4,611,000 | 0,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 6,146,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genfar S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
